In some countries, this medicine may only be approved for veterinary use.
ATC (Anatomical Therapeutic Chemical Classification)
CAS registry number (Chemical Abstracts Service)
Pyrrolidine, 1-[3-metyl-4-(4-morpholinyl)-1-oxo-2,2-diphenylbutyl]-, (S)-
- Dextromoramidum (Latin)
- Dextromoramid (German)
- Dextromoramide (French)
- Dextromoramida (Spanish)
- Destromoramide (OS: DCIT)
- Dextromoramide (OS: DCF, BAN)
- MCP 875 (IS)
- R 875 (IS)
- Dextromoramide Tartrate (OS: BANM)
- Dextromoramide acid tartrate (IS)
- Pyrrolamidol (IS)
- SKF 5137 (IS)
- Dextromoramide (tartrate de) (PH: Ph. Eur. 9)
- Dextromoramide Tartrate (PH: BP 2018)
- Dextromoramide tartrate (PH: Ph. Eur. 9)
- Dextromoramidhydrogentartrat (PH: Ph. Eur. 9)
- Dextromoramidi tartras (PH: Ph. Eur. 9)
- Zinexan [+ Quinidine]
Teva Argentina, Argentina
- Palface 5 mg/ml [veterinary use]
|BAN||British Approved Name|
|BANM||British Approved Name (Modified)|
|DCF||Dénomination Commune Française|
|DCIT||Denominazione Comune Italiana|
|Prop.INN||Proposed International Nonproprietary Name (World Health Organization)|
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.